The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAscential Regulatory News (ASCL)

Share Price Information for Ascential (ASCL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 314.80
Bid: 313.40
Ask: 314.00
Change: 3.80 (1.22%)
Spread: 0.60 (0.191%)
Open: 315.00
High: 315.00
Low: 309.60
Prev. Close: 311.00
ASCL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Company Secretary Change

1 Feb 2024 14:48

RNS Number : 7558B
Ascential PLC
01 February 2024
 

1 February 2024

 

ASCENTIAL PLC

 

COMPANY SECRETARY CHANGE

 

Ascential plc ("Ascential") announces that Louise Meads, Group Company Secretary since February 2017, is to step down and be succeeded with effect from 1 February 2024 by Naomi Howden, who is currently Deputy Company Secretary. The board would like to thank Louise for her excellent service and contribution through a period of significant change in the business and wish her well for the future.

 

 

 

 

 

About Ascential plc:

 

Ascential takes the world's leading brands to the heart of what's next for their industries. We do this through our events, intelligence products and advisory services. Our 700 people serve a global customer base from more than 100 countries in the large and growing Marketing and Financial Technology sectors. Ascential is listed on the London Stock Exchange (LON: ASCL). ascential.com

 

Enquiries:

 

Ascential plc

Philip Thomas, Chief Executive Officer

+44 (0)20 7516 5000

Mandy Gradden, Chief Financial Officer

Rory Elliott, Investor Relations Director

FTI Consulting LLP, Media enquiries

Matt Dixon

+44 (0)20 3727 1000

Jamie Ricketts

Edward Bridges

 

 

 

IMPORTANT NOTICES

The person responsible for arranging the release of this announcement on behalf of Ascential is Naomi Howden, Company Secretary.

 

This announcement contains "forward-looking statements" which includes all statements other than statements of historical fact, including, without limitation, those regarding the Company's financial position, business strategy, plans and objectives of management for future operations, or any statements preceded by, followed by or that include the words "targets", "believes", "expects", "aims", "intends", "will", "may", "anticipates", "would, "could" or similar expressions or negatives thereof. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors beyond the Company's control that could cause the actual results, performance or achievements of the Company to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. Such forward-looking statements are based on numerous assumptions regarding the Company's present and future business strategies and the environment in which the Company will operate in the future. These forward-looking statements speak only as at the date of this announcement.

 

Neither the Company nor its affiliates undertakes or is under any duty to update this announcement or to correct any inaccuracies in any such information which may become apparent or to provide you with any additional information, other than any requirements that the Company may have under applicable law or the Listing Rules, the Prospectus Regulation Rules, the Disclosure Guidance and Transparency Rules or the Market Abuse Regulation MAR (EU No. 596/2014) as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018). To the fullest extent permissible by law, such persons disclaim all and any responsibility or liability, whether arising in tort, contract or otherwise, which they might otherwise have in respect of this announcement. The information in this announcement is subject to change without notice.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
COSDZGGZDMVGDZM
Date   Source Headline
22nd Apr 20243:39 pmRNSResults of General Meeting
18th Apr 20246:14 pmRNSDirector/PDMR Shareholding
11th Apr 202410:12 amRNSHolding(s) in Company
10th Apr 20241:48 pmRNSHolding(s) in Company
10th Apr 202410:32 amRNSNotice of AGM
9th Apr 20243:37 pmRNSHolding(s) in Company
8th Apr 20245:09 pmRNSHolding(s) in Company
5th Apr 20243:18 pmRNSHolding(s) in Company
4th Apr 20241:45 pmRNSHolding(s) in Company
4th Apr 20247:00 amRNSProposed Return of Value of £850m to Shareholders
3rd Apr 202410:39 amRNSHolding(s) in Company
2nd Apr 202412:12 pmRNSHolding(s) in Company
2nd Apr 202412:00 pmRNSTotal Voting Rights
28th Mar 20242:25 pmRNSHolding(s) in Company
28th Mar 202411:33 amRNSHolding(s) in Company
27th Mar 202412:02 pmRNSHolding(s) in Company
26th Mar 202412:16 pmRNSHolding(s) in Company
25th Mar 20243:40 pmRNSHolding(s) in Company
25th Mar 20242:26 pmRNSHolding(s) in Company
22nd Mar 20242:20 pmRNSHolding(s) in Company
21st Mar 20243:38 pmRNSHolding(s) in Company
21st Mar 20247:00 amRNSUnaudited full year results 2023
13th Mar 20244:49 pmRNSHolding(s) in Company
12th Mar 20241:24 pmRNSHolding(s) in Company
1st Mar 20242:25 pmRNSTotal Voting Rights
29th Feb 202410:22 amRNSHolding(s) in Company - Correction
27th Feb 20241:12 pmRNSHolding(s) in Company
22nd Feb 20245:01 pmRNSHolding(s) in Company
20th Feb 20241:26 pmRNSHolding(s) in Company
16th Feb 20241:06 pmRNSHolding(s) in Company
15th Feb 20244:08 pmRNSHolding(s) in Company
7th Feb 20243:40 pmRNSHolding(s) in Company
6th Feb 20244:06 pmRNSTotal Voting Rights
6th Feb 20241:41 pmRNSHolding(s) in Company
5th Feb 20241:05 pmRNSHolding(s) in Company
1st Feb 20242:48 pmRNSCompany Secretary Change
1st Feb 202411:35 amRNSCompletion of the sale of WGSN
5th Jan 20242:52 pmRNSBlock listing Interim Review
5th Jan 20247:49 amRNSDirector/PDMR Shareholding
4th Jan 202412:53 pmRNSHolding(s) in Company
2nd Jan 202411:21 amRNSUpdate on Sale Processes, Governance and Financing
29th Dec 202310:00 amRNSDirector/PDMR Shareholding
18th Dec 202310:10 amRNSResults of General Meeting
1st Dec 202312:28 pmRNSPublication of Circular and Notice of General Mtg
27th Nov 202310:31 amRNSDirector/PDMR Shareholding
22nd Nov 202312:03 pmRNSHolding(s) in Company
16th Nov 202311:57 amRNSHolding(s) in Company
6th Nov 20232:46 pmRNSHolding(s) in Company
6th Nov 202312:22 pmRNSHolding(s) in Company
3rd Nov 20232:43 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.